Pharma dollars back patient groups that oppose Medicare Part B overhaul
(By Ed Silverman for STAT) After the Obama administration proposed overhauling Medicare Part B earlier this year, a plethora of
Read More
Part D/Prescription Drugs
Elizabeth Warren demands open access to data from patient trials of drugs
(By Meghana Keshavan for STAT) Should researchers make public all the data they collect when testing drugs and medical devices
Read MoreWhere’s the Patient in the Equation?
In response to rising cost of prescription drugs, a handful of organizations have developed frameworks for assessing the value of
Read MoreFDA warns Chinese drug maker over lying
(By Ed Silverman for STAT) The next time that employees at Xiamen Origin Biotech want to lie to regulators about
Read MoreIn cancer, it’s back to the future as old treatments make cutting-edge ones more effective
(By Sharon Begley for STAT) New cancer drugs that unleash the immune system on tumors are all the rage, getting
Read MoreUS researchers now testing Zika vaccines in human subjects
(By Andrew Joseph for STAT) Federal health researchers have started testing an experimental Zika vaccine in people, officials announced Wednesday.
Read MoreThere’s a possible cure for ‘bubble boy’ disease. It will cost $665,000
(By Damian Garde for STAT) GlaxoSmithKline has developed what looks like a cure for a rare and deadly disease, and
Read MoreMost Californians support a measure to obtain state discounts on drugs
(By Ed Silverman for STAT) The pharmaceutical industry may be losing a heated battle over drug prices in California. Continue
Read MoreGilead fires back at medical journal report critical of its pricing
(By Ed Silverman for STAT) After getting beaten up last week over the pricing of its hepatitis C treatments in
Read MorePharmacy benefit managers are restricting access to lots of drugs next year
(By Ed Silverman for STAT) In the latest bid to control prescription drug spending, the nation’s largest pharmacy benefits managers
Read More